• Presentation

What Have We Learned from Safety Cases for New Drug Development? Industry Responding to Learning from Safety Cases

Citation

Perez-Gutthann, S. (2007, April). What Have We Learned from Safety Cases for New Drug Development? Industry Responding to Learning from Safety Cases. Presented at The International Society for Pharmacoepidemiology (ISPE) 2007 Mid-Year Meeting, .

Abstract